title: Repeated intravenous cocaine experience: development and escalation of pre-drug anticipatory 50-kHz ultrasonic vocalizations in rats.
abstract: Ultrasonic vocalization (USV) in the 50-kHz range occurs in rats immediately upon first-time exposure to cocaine or amphetamine, and rapidly increases with repetitive drug exposure at the same dose. This sensitized positive-affect response to these drugs of abuse is persistent in that the peak level of USVs again appears when the drug is reintroduced after several weeks of drug discontinuation. The present study explored whether with enough experience USVs might be elicited, and gradually escalate, in anticipation of impending drug delivery. Rats were trained to self-administer (SA) cocaine intravenously by lever pressing 5 days per week for 4 weeks. Yoked rats received experimenter-delivered cocaine matching that of SA rats. USVs and locomotor activity were recorded during each 10-min period prior to 60-min drug access sessions. Extinction trials in which drug access was denied were then carried out over an additional 4-week period. After about a week of cocaine experience, both the SA and yoked groups began to progressively increase USVs when placed in an environment that predicted forthcoming drug exposure. Extinction of anticipatory calls and locomotion occurred over days after drug access ended. USVs may be a useful model for specifically investigating the neural basis of drug anticipation and aid in developing and assessing new addiction treatment strategies for reducing craving and relapse.
authors.affiliation: Department of Psychology and Institute for Neuroscience, University of Texas, Austin, TX 78712, USA.
authors.forename: Sean T
authors.initials: ST
authors.lastname: Ma
authors.forename: Esther Y
authors.initials: EY
authors.lastname: Maier
authors.forename: Allison M
authors.initials: AM
authors.lastname: Ahrens
authors.forename: Timothy
authors.initials: T
authors.lastname: Schallert
authors.forename: Christine L
authors.initials: CL
authors.lastname: Duvauchelle
mesh_terms: D000704:Analysis of Variance; D000779:Anesthetics, Local / Q000008:administration & dosage*; D000818:Animals; D003042:Cocaine / Q000008:administration & dosage*; D003216:Conditioning, Operant / Q000187:drug effects; D007275:Injections, Intravenous / Q000379:methods; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D012646:Self Administration / Q000379:methods; D014465:Ultrasonics; D014828:Vocalization, Animal / Q000187:drug effects*
chemical_list: D000779:Anesthetics, Local; D003042:Cocaine
references.citation: J Subst Abuse Treat. 1989;6(2):95-106
references.pmid: 2746717
references.citation: Behav Neurosci. 2009 Apr;123(2):328-36
references.pmid: 19331456
references.citation: Biol Psychiatry. 2005 Nov 1;58(9):751-9
references.pmid: 16098484
references.citation: Neurosci Lett. 2009 Mar 27;453(1):31-5
references.pmid: 19429010
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4321-6
references.pmid: 10760299
references.citation: Behav Brain Res. 2009 Feb 11;197(2):311-6
references.pmid: 18793676
references.citation: Science. 2004 Aug 13;305(5686):1017-9
references.pmid: 15310907
references.citation: Psychopharmacology (Berl). 1997 Sep;133(1):7-16
references.pmid: 9335075
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1178-87
references.pmid: 16507711
references.citation: J Comp Psychol. 2008 Nov;122(4):357-67
references.pmid: 19014259
references.citation: Curr Protoc Neurosci. 2007 Jul;Chapter 8:Unit 8.1
references.pmid: 18428664
references.citation: Am J Psychiatry. 1999 Jan;156(1):11-8
references.pmid: 9892292
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Addiction. 2002 Apr;97(4):459-69
references.pmid: 11964061
references.citation: Psychopharmacology (Berl). 1996 Jun;125(3):202-8
references.pmid: 8815954
references.citation: Behav Brain Res. 2005 May 7;160(1):34-43
references.pmid: 15836898
references.citation: Neurosci Biobehav Rev. 2006;30(2):173-87
references.pmid: 16099508
references.citation: Behav Pharmacol. 2007 Jul;18(4):297-302
references.pmid: 17551322
references.citation: Neuroscience. 2007 Dec 5;150(2):291-8
references.pmid: 17942235
references.citation: Eur J Neurosci. 2004 Jul;20(1):273-80
references.pmid: 15245499
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46
references.pmid: 18640920
references.citation: Psychol Bull. 2002 Nov;128(6):961-77
references.pmid: 12405139
references.citation: Behav Neurosci. 2009 Aug;123(4):913-25
references.pmid: 19634952
references.citation: ILAR J. 2009;50(1):43-50
references.pmid: 19106451
references.citation: Psychol Rev. 1984 Apr;91(2):251-68
references.pmid: 6571424
references.citation: Psychopharmacology (Berl). 2000 Jul;151(1):13-8
references.pmid: 10958111
references.citation: Brain Res. 2000 Apr 17;862(1-2):49-58
references.pmid: 10799668
references.citation: Behav Neurosci. 2008 Apr;122(2):310-30
references.pmid: 18410171
references.citation: Behav Brain Res. 2009 Jan 30;197(1):205-9
references.pmid: 18809437
references.citation: J Comp Psychol. 1998 Mar;112(1):65-73
references.pmid: 9528115
references.citation: Neuropsychopharmacology. 2008 Sep;33(10):2352-61
references.pmid: 18059435
references.citation: J Exp Psychol Anim Behav Process. 1991 Jul;17(3):231-48
references.pmid: 1890383
references.citation: Behav Brain Res. 2007 Sep 4;182(2):274-83
references.pmid: 17449117
references.citation: Behav Brain Res. 2008 Jan 10;186(1):48-56
references.pmid: 17719099
references.citation: Int J Neuropsychopharmacol. 2010 Feb;13(1):123-32
references.pmid: 19545474
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):166-80
references.pmid: 17805308
references.citation: Drug Alcohol Depend. 2006 Feb 28;81(3):275-82
references.pmid: 16146672
references.citation: Neuropharmacology. 2004;47 Suppl 1:33-46
references.pmid: 15464124
references.citation: Neuropharmacology. 2008 Oct;55(5):771-9
references.pmid: 18634806
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):653-67
references.pmid: 16932924
references.citation: Physiol Behav. 1999 Jun;66(4):639-43
references.pmid: 10386908
references.citation: Physiol Behav. 2009 Mar 23;96(4-5):620-30
references.pmid: 19150452
references.citation: Behav Neurosci. 2000 Apr;114(2):320-7
references.pmid: 10832793
references.citation: Behav Brain Res. 2007 Sep 4;182(2):284-9
references.pmid: 17397940
references.citation: Nat Neurosci. 2005 Nov;8(11):1481-9
references.pmid: 16251991
references.citation: Science. 2004 Aug 13;305(5686):1014-7
references.pmid: 15310906
references.citation: Neuropsychopharmacology. 2002 Jun;26(6):703-15
references.pmid: 12007741
references.citation: Neuropsychopharmacology. 2001 Sep;25(3):361-72
references.pmid: 11522464
references.citation: Addict Biol. 2007 Sep;12(3-4):227-462
references.pmid: 17678505
references.citation: Psychopharmacology (Berl). 1998 Oct;139(3):169-84
references.pmid: 9784071
references.citation: Behav Neurosci. 2000 Oct;114(5):983-90
references.pmid: 11085613